Indivior | 销售成本



Cost Of Sales 更改 日
AstraZeneca USD 2.72B 263M 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Glaxosmithkline GBP 2.52B 199M 2024-12
Halozyme Therapeutics USD 42.06M 7.37M 2024-12
Indivior 59M 7M 2024-09
J&J USD 7.3B 189M 2025-03
Kyowa Hakko Kirin JPY 34.54B 657M 2024-09
Merck USD 3.71B 181M 2024-12
Novartis USD 3.31B 73M 2024-12
Pfizer USD 5.65B 781M 2024-12
Sanofi EUR 2.27B 1.81B 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12



Indivior 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.